EndoTODAY | EndoATLAS | ¿Ü·¡¼³¸íÀÚ·á

±â»ýÃæ | ½Äµµ | À§ | À§¾Ï | ESD | õ±â´©¼³

Home | Guide | ÁÖÀÎÀå | ±¸µ¶ | °Ë»ö | ¸µÅ©


[ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½ÉÁý´ãȸ 2016-5-19]

Previous | Next

1. ¹«Áõ»ó ½Äµµ Ä­µð´ÙÁõ

1 ³â °£°ÝÀ¸·Î ¸Å³â ³»½Ã°æ °Ë»ç¸¦ ¹Þ¾Ò½À´Ï´Ù.

°ÇÁø¿¡¼­ ¸Å³â Candidasis°¡ ³ª¿Í ÀÇ·ÚµÇ¾î ¸Å³â fluconazoleÀ» µå·È´Ù°í ÇÕ´Ï´Ù. ±×·±µ¥ ¸î ³â ¿¬¼Ó ³ª¿À´Ù°¡ ¾î´À ÇغÎÅÍ ³ª¿ÀÁö ¾Ê¾Ò½À´Ï´Ù. ¾îÂîµÈ ¿µ¹®ÀÎÁö ¾Ë ¼ö ¾ø½À´Ï´Ù. ¸é¿ªÀúÇÏȯÀÚ°¡ ¾Æ´Ñ °æ¿ì ¹«Áõ»ó½ÄµµÄµµð´ÙÁõÀº Áß¿äÇÑ Áúº´À¸·Î ÁøÇàÇÏÁö ¾Ê´Â self-limited disease°¡ ºÐ¸íÇÑ °Í °°½À´Ï´Ù. °Ë»çÇÏ°í °á°úÆǵ¶À» ÇÏ´Â Àǻ簡 Àß ¼³¸íÇÏ°í ÀÇ·ÚÇÏÁö ¾ÊÀ¸¸é Ä¡·áÇÏÁö ¾Ê°í °æ°ú°üÂûÀ» ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÏ´Ü È¯ÀÚ¸¦ ÀÇ·Ú¹ÞÀ¸¸é Ä¡·áÇÏÁö ¾Ê±â´Â ¾î·Æ½À´Ï´Ù.

°ü·ÃÇÏ¿© ÃÖ±Ù °Ç±¹´ëÇб³ º´¿ø¿¡¼­ ¹«Áõ»ó ½Äµµ Ä­µð´ÙÁõÀÇ ÀÚ¿¬ °æ°ú¿¡ ´ëÇÑ ³í¹®À» ¹ßÇ¥ÇÑ ¹Ù ÀÖ½À´Ï´Ù (Lee SP. Scand J Gastroenterol 2015). Ä¡·á°¡ ÇÊ¿äÇÏÁö ¾Ê´Ù´Â °á·ÐÀÔ´Ï´Ù.

MATERIALS AND METHODS: A total of 49,497 subjects who underwent a health inspection that included upper endoscopy were enrolled. We retrospectively reviewed the subject's self-reporting questionnaires, medical records and endoscopic findings. We considered "long-term" follow-up to be >6 months with at least one more follow-up endoscopy.

RESULTS: One hundred and seventy (0.4%) subjects were endoscopically diagnosed as esophageal candidiasis and 141 subjects were AEC. Multivariate analysisrevealed that old age (¡Ã60 years) was an independent risk factor for AEC (OR, 1.862, p = 0.005). The number of subjects with long-term follow-up was 79 (195.3 person-years). Among these, AEC of 64 subjects (81.0%) had disappeared on the follow-up endoscopy and was not recurrent. The other 15 subjects had AEC diagnosed more than once on the follow-up endoscopy, and 5 of them were spontaneously healed during the follow-up period. The remaining 10 subjects whose candidiasis was sustained up to the last endoscopy did not complain of symptoms during the follow-up period, and their endoscopic findings did not worsen.

CONCLUSIONS: AEC is rare and old age is the only risk factor. AEC (asymptomatic esophageal candidiasis) does not require medical care because it is a self-limited disease.

Àú´Â ³»½Ã°æ °Ë»ç µµÁß ¹«Áõ»ó ½Äµµ ĵµð´ÙÁõÀº ½½Â½ ¹«½ÃÇϱ⵵ ÇÕ´Ï´Ù. ÇǺΰú Àǻ簡 ¸ðµç Á¡¿¡ ´ëÇÏ¿© comment ÇÏÁö ¾Ê´Â °Íó·³...

* Âü°í: EndoTODAY ½ÄµµÄ­µð´ÙÁõ


2. Inflammatory fibrinoid polyp

Inflammatory fibrinoid polypÀº gastric submucosal granuloma with eosinophilic infiltration, eosinophilic granuloma, hemangiopericytoma, fibroma, inflammatory pseudotumor µî ´Ù¾çÇÑ À̸§À¸·Î ºÒ·È´ø Á¾¾çÀÔ´Ï´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¼¶À¯Á¶Á÷, Ç÷°ü, È£»ê±¸¸¦ Æ÷ÇÔÇÑ ¸¹Àº ¿°Áõ¼¼Æ÷µé·Î ±¸¼ºµÇ¾î ÀÖ°í ±¹¼ÒÀûÀÎ ºñ½Å»ý¼º ¼ºÀåÀ» ÇÏ´Â ÁúȯÀÔ´Ï´Ù. ÁÖ·Î À§¿¡ ¹ß»ýÇÏÁö¸¸ µå¹°°Ô ¼ÒÀå, ´ëÀå, ½Äµµ¿¡¼­µµ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾Ç¼ºº¯È­´Â º¸°íµÈ ¹Ù ¾ø½À´Ï´Ù. À§³»½Ã°æ¿¡¼­´Â ÁÖ·Î pedunculated polypÀÇ ÇüÅ°¡ ¸¹Àºµ¥ SMT¿Í ºñ½ÁÇÏ°Ô º¸ÀÌ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

IFP arises from submucosa of the GI tract. It consists of loose connective tissue with a rich vasculature and abundant fibrous component. Usually the lesion was sessile or polypoid with ulceration of the overlying mucosa.

SMTó·³ º¸¿´´ø °æ¿ìÀÌ°í wedge resectionÀ¸·Î È®ÁøÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù. ¼ö¼úÀü impressionÀº GIST¿´½À´Ï´Ù.

Inflammatory fibrinoid polyp


3. ³»½Ã°æ À°¾È¼Ò°ß »ó ¼±Á¾À» ÀǽÉÇÏ¿´´ø Á¶±âÀ§¾Ï

ù ³»½Ã°æ

ÀÇ·Ú ÈÄ Àç°Ë

Stomach, subtotal gastrectomy:
Early gastric carcinoma
1. Location : lower third, Center at angle and anterior wall
2. Gross type : EGC type IIa
3. Histologic type : tubular adenocarcinoma, poorly differentiated
4. Histologic type by Lauren : diffuse
5. Size : 2.1x1.2 cm
6. Depth of invasion : invades mucosa (muscularis mucosae) (pT1a)
7. Resection margin: free from carcinoma, safety margin: proximal 3 cm, distal 5 cm
8. Lymph node metastasis : no metastasis in 32 regional lymph nodes (pN0)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : not identified


4. Recurrent ulcer with outlet obstruction

ºóÇ÷°ú ¾îÁö·¯¿òÀ¸·Î ³»¿øÇϼ̽À´Ï´Ù. Ç÷»ö¼Ò´Â 7À̾ú°í öÀº 5¿´½À´Ï´Ù. Á¶Á÷°Ë»ç¿¡¼­´Â Hp (+) gastritis·Î¸¸ ³ª¿Í Á¦±ÕÄ¡·á¿Í À§»êºÐºñ¾ïÁ¦Á¦¸¦ Åõ¿©ÇÏ¿´½À´Ï´Ù. ȯÀÚ°¡ Àá½Ã follow up lossµÈ ÈÄ ´Ù½Ã ¿À¼Ì´Âµ¥ ¾Æ·¡ »çÁø°ú °°¾Ò½À´Ï´Ù. Ç︮ÄÚ¹ÚÅÍ°¡ Á¦±ÕµÇÁö ¾ÊÀº »óÅ¿´°í Ãß°¡Ä¡·á ÈÄ È£ÀüµÇ¾ú½À´Ï´Ù.

Àú´Â ¾ÏÀ¸·Î ÆÇ´ÜÇÏ¿´´Âµ¥ ÃÖÁ¾ °á°ú°¡ recurrent ulcer·Î ³ª¿Í Á¶±Ý âÇÇÇß½À´Ï´Ù. À§¾Ï°ú À§±Ë¾çÀÇ ±¸ºÐÀº ´Ã ¾î·Æ½À´Ï´Ù. ³»½Ã°æÀ» 25³â° ÇÏ°í Àִµ¥ ¿©ÀüÈ÷ ¾î·Æ½À´Ï´Ù.


5. A colon LST

A colonÀÇ LSTÀÔ´Ï´Ù. Á¶Á÷°Ë»ç°¡ hyperplastic polypÀ¸·Î ³ª¿ÔÀ¸³ª EMRÀ» ÇÏ¿´°í ÃÖÁ¾ °á°ú´Â serrated adenoma·Î ³ª¿Ô½À´Ï´Ù.

* Âü°í: EndoTODAY Serrated adenoma


[References]

1) SMC Endoscopy Unit »ï¼º¼­¿ïº´¿ø ³»½Ã°æ½Ç

2) SMC Monday GI conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½É¼ÒÈ­±âÁý´ãȸ

3) SMC Thursday endoscopy conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ

© EndoTODAY Endoscopy Learning Center. Jun Haeng Lee.